Foundation for Liver Research

Recent papers from Foundation for Liver Research

1. Vertical Sleeve Gastrectomy inhibits 11βHSD1 and subsequently reduces IL6 secretion in Mice and Humans: A Shared Anti-Inflammatory MechanismJournal of Endocrinology · 2026
2. Impact of YAQ001 on the Gut Microbiome, Permeability and Markers of Systemic Inflammation in Patients With CirrhosisLiver International · 2026
3. Adjuvant pegylated interferon-alpha after nucleos(t)ide analog withdrawal drives a temporally coordinated expansion of regulatory B cells and contraction of HBV-specific T cellsHepatology · 2026
4. A call for action with the burden of cirrhosis in AustraliaAustralian Health Review · 2026
5. Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective studyJournal of Hepatology · 2026
6. Extensive and differential platinum chemotherapy mutagenesis in livers of childrenScience · 2026
7. Bioactive glasses-mediated ion therapy ameliorates hepatic osteodystrophy by reprogramming the liver-bone axisBioactive Materials · 2026
8. Medical therapy of MASLD – consequences of the paradigm shift from histology to non-invasive testsJHEP Reports · 2026
9. Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial)Hepatology · 2026
10. PROMISE: a PROspective randomised double-blind parallel group placebo-controlled multicentre trial of faecal MIcrobiota tranSplantation to improve outcomEs in patients with cirrhosis over 24 months—study protocol for a clinical trialTrials · 2026
11. Serum Receptor-Interacting Protein Kinase 3 (RIPK3) Is Associated with Transplant-Free Survival in Acute Liver FailureJHEP Reports · 2026
12. Long-term mortality in patients admitted acutely for chronic liver disease in England: A national cohort studyEuropean Journal of Internal Medicine · 2026
13. Prospective evaluation of a pilot implementation of liver health checks in primary care in EnglandFrontline Gastroenterology · 2026
14. Implications of new obesity definitions in the classification and outcomes of patients with MASLDHepatology · 2026
15. Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging StudyNature Medicine · 2026
16. Single-cell insights into hepatic fibroblasts and stellate cells: heterogeneity in matrix remodelling in development, health, and diseasenpj gut and liver. · 2026
17. A data-driven framework reconstructs the molecular continuum of human MASLD progressionNature Metabolism · 2026
18. Non-absorbable antibiotics worsen alcohol-associated liver disease in gastric acid-suppressed miceGut Microbes · 2026
19. Delphi survey to explore core curriculum for training the next-generation of hepatologists☆JHEP Reports · 2026
20. Progression of MASH to cirrhosis, decompensation, and mortality, and the utility of NITs for detection and risk stratificationHepatology Communications · 2026